The number of people with susceptibility test result for rifampicin in Congo
Congo: The number of people with susceptibility test result for rifampicin was 42.71 in 2021. ◆ Volatile
Latest (2021)
42.71
Change on year
down 57.3%
World rank
122nd
of 146 countries
All-time high
100
in 2020
All-time low
1.94
in 2017
Years of data
5
2017–2021
The number of people with susceptibility test result for rifampicin in Congo, 2017–2021
Source: World Health Organization, Global Health Observatory.
Analysis
In 2021, the number of people with susceptibility test result for rifampicin in Congo stood at 42.71.
The figure is down 57.3% on the previous year and up 2,096.6% over five years.
Congo ranks 122nd of 146 countries on this measure, in the bottom quarter.
The number of people with susceptibility test result for rifampicin in Congo, year by year
| Year | Value | Change |
|---|---|---|
| 2017 | 1.94 | — |
| 2018 | 15.35 | +689.7% |
| 2019 | 28.89 | +88.2% |
| 2020 | 100 | +246.1% |
| 2021 | 42.71 | -57.3% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2010s | 15.4 | 1.94 | 28.89 | 3 |
| 2020s | 71.35 | 42.71 | 100 | 2 |
Countries ranked near Congo
More health data for Congo
- Un projection of annual infant deaths, annual growth rate -0.4813 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.9705 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 759.5 deaths per 1,000 people (2090)
- Number of infants who die before age 1 2,688 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 11 (2025)
- Population ages 00-04, female, annual growth rate 1.44 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0695 units per person (2025)
- Population ages 00-04, male, annual growth rate 1.45 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is the number of people with susceptibility test result for rifampicin in Congo?
- The number of people with susceptibility test result for rifampicin in Congo was 42.71 in 2021, according to World Health Organization, Global Health Observatory.
- What is the highest the number of people with susceptibility test result for rifampicin recorded in Congo?
- The highest recorded value was 100 in 2020.
- What is the lowest the number of people with susceptibility test result for rifampicin recorded in Congo?
- The lowest recorded value was 1.94 in 2017.
- How does Congo rank for the number of people with susceptibility test result for rifampicin?
- Congo ranks 122nd out of 146 countries with data for 2021.
- Where does this Congo data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients expressed as percentage.. Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 5 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).